Luca Simula

10PUBLICATIONS
21CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 21, 2025
Degrading cancer cell mitochondria to improve T cell-mediated killing.

Luca Simula, Emmanuel Donnadieu

|Feb 19, 2025
Inhibition of Atg7 in intestinal epithelial cells drives resistance against Citrobacter rodentium.

David Cune, Caterina Luana Pitasi, Alessia Rubiola

|Mar 12, 2024
Mitochondrial metabolism sustains CD8+ T cell migration for an efficient infiltration into solid tumors.

Luca Simula, Mattia Fumagalli, Lene Vimeux

|Aug 30, 2023
FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors.

Maude Marchais, Luca Simula, Mélanie Phayanouvong

|Jun 10, 2022
Immune Checkpoint Proteins, Metabolism and Adhesion Molecules: Overlooked Determinants of CAR T-Cell Migration?

Luca Simula, Emma Ollivier, Philippe Icard

|May 28, 2022
How Phosphofructokinase-1 Promotes PI3K and YAP/TAZ in Cancer: Therapeutic Perspectives.

Luca Simula, Marco Alifano, Philippe Icard

Pageof 2

Frequent Collaborators

3 joint publications

Silvia Campello

3 joint publications

Emmanuel Donnadieu

2 joint publications

Ignazio Caruana

2 joint publications

Philippe Icard